Breast: cancer-metastasis-normal
Home Up Normal organs Evaluation slide (TEST SLIDE) Various cancers Normal organs and cancers prostate cancer Breast: cancer-metastasis-normal lung cancer Lung: cancer-metastasis-normal Normal lung tissue colon and rectum cancer colorectal: cancer-metastasis-normal Normal colon and rectum tissue larynx and pharynx cancer Ovary cancer Kidney cancer Stomach cancer Normal stomach tissue Esophagus cancer Liver cancer Liver: cancer-metastasis-normal Non-neoplastic liver tissue Thyroid cancer Lipomatous tumors Skin cancer Normal endometrium

 

 Category Human tissue array
   Cat. No. CBA
   Product description Breast: cancer-metastasis-normal
   Data sheet CBA2
CBA2
   
   Images
  general_information
   No. of samples 60
   Text
current version : CBA2
breast cancer : 40 cores
metastatic cancer : 10 cores
nipple : 2 cores
normal : 8 cores

Price : 5 slide for 600 €

CBA2 Human Breast Cancer
   Sex   Age  Organ    Diagnosis    T stage    LN*    ER**    PR**    p53  
 1    F    28    Breast    infiltrating duct carcinoma    T4   uk    +    －   - 
 2    F    71    Breast    solid papillary carcinoma    T4b   2/12    +    +    - 
 3    F    26    Breast    infiltrating duct carcinoma    T4b   22/25    +    －   - 
 4    F    43    Breast    infiltrating duct carcinoma    T4b   4/13    +    +    - 
 5    F    39    Breast    infiltrating duct carcinoma    T3   0/37    -   －   +  
 6    F    46    Breast    ductal carcinoma in situ    T3   14/15    +    +    - 
 7    F    47    Breast    infiltrating duct carcinoma    T2   37/41    -   －   +  
 8    M    67    Breast    infiltrating duct carcinoma    T3   1/12    +    +    - 
 9    F    33    Breast    infiltrating duct carcinoma    T3   25/25    +    +    - 
 10    F    47    Breast    infiltrating duct carcinoma    T2   0/15    +    +    - 
 11    F    49    Breast    infiltrating lobular carcinoma    T2   1/14    -   －   - 
 12    F    46    Breast    infiltrating duct carcinoma    T3   2/25    +    －   - 
 13    F    39    Breast    infiltrating duct carcinoma    T2   2/19    +    uk    - 
 14    F    43    Breast    infiltrating lobular carcinoma    T3   25/25    -   －   - 
 15    F    54    Breast    infiltrating lobular carcinoma    T3   28/31    +    －   +  
 16    F    58    Breast    infiltrating duct carcinoma    T4b   1/15    -   －   - 
 17    F    37    Breast    infiltrating duct carcinoma    T2   2/14    +    +    +  
 18    F    43    Breast    infiltrating duct carcinoma    T2   0/13    -   －   +  
 19    F    51    Breast    infiltrating duct carcinoma    T2   0/20    +    +    - 
 20    F    80    Breast    medullary carcinoma    T3   4/28    -   －   +  
 21    F    36    Breast    infiltrating duct carcinoma    T2   7/24    -   －   - 
 22    F    59    Breast    infiltrating duct carcinoma    T2   16/25    +    +    - 
 23    F    34    Breast    ductal carcinoma in situ    T3   0/5    -   －   +  
 24    F    54    Breast    infiltrating duct carcinoma    T3   8/8    +    +    +  
 25    F    47    Breast    infiltrating duct carcinoma    T2   0/22    +    +    - 
 26    F    53    Breast    infiltrating duct carcinoma    T2   0/12    -   －   +  
 27    F    59    Breast    infiltrating duct carcinoma    T2   3/24    +    －   - 
 28    F    60    Breast    signet ring cell carcinoma    T3   0/7    +    +    - 
 29    F    37    Breast    infiltrating duct carcinoma    T3   7/21    -   +    +  
 30    F    46    Breast    infiltrating duct carcinoma    T2   0/17    +    －   - 
 31    F    35    Breast    infiltrating duct carcinoma    T3   8/14    +    －   - 
 32    F    47    Breast    infiltrating duct carcinoma    T2   0/26    -   －   +  
 33    F    54    Breast    infiltrating duct carcinoma    T2   0/17    +    +    - 
 34    F    47    Breast    infiltrating duct carcinoma    T2   8/17    -   －   +  
 35    F    41    Breast    infiltrating duct carcinoma    T3   0/6    +    +    - 
 36    F    38    Breast    infiltrating duct carcinoma    T3   2/6    -   －   +  
 37    F    55    Breast    infiltrating duct carcinoma    T2   3/21    -   －   +  
 38    F    65    Breast    infiltrating duct carcinoma    T2   0/9    +    －   - 
 39    M    66    Breast    infiltrating duct carcinoma    T1c   5/14    -   －   - 
 40    F    44    Breast    infiltrating duct carcinoma    T3   1/12    +    －   +  
 41    F    52    Breast    metastatic carcinoma in lymph node    T3   10/22    -   －   +  
 42    F    32    Breast    metastatic carcinoma in lymph node    T3   20/23    +    +    - 
 43    F    58    Breast    metastatic carcinoma in lymph node    T3   22/22    +    +    +  
 44    F    52    Breast    metastatic carcinoma in lymph node    T3   24/24    -   －   - 
 45    F    58    Breast    metastatic carcinoma in lymph node    T2   4/20    -   －   +  
 46    F    38    Breast    metastatic carcinoma in lymph node    T1c   1/8    +    +    - 
 47    F    45    Breast    metastatic carcinoma in lymph node    T1c   9/23    -   －   - 
 48    F    45    Breast    metastatic carcinoma in lymph node    T2   11/20    +    +    - 
 49    F    29    Breast    metastatic carcinoma in lymph node    T2   8/10    -   －   +  
 50    F    61    Breast    metastatic carcinoma in lymph node    T1b   22/26    -   －   - 
 51    F    46    Breast    nipple    .    .    .    .    .  
 52    F    47    Breast    nipple    .    .    .    .    .  
 53    F    40    Breast    normal    .    .    .    .    .  
 54    F    43    Breast    normal    .    .    .    .    .  
 55    F    40    Breast    normal    .    .    .    .    .  
 56    F    40    Breast    normal    .    .    .    .    .  
 57    F    45    Breast    normal    .    .    .    .    .  
 58    F    44    Breast    normal    .    .    .    .    .  
 59    F    37    Breast    normal    .    .    .    .    .  
 60    F    51    Breast    normal    .    .    .    .    .  

General Information of the Tissue Array Slide

Applications

  • 􀁺 Immunohistochemistry
  • 􀁺 In situ hybridization, RNA or DNA
  • 􀁺 Fluorescent in situ hybridization (FISH)
  • 􀁺 In situ PCR, RNA or DNA
  • 􀁺 TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)

Storage and stability

  • 􀁺 Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
  • 􀁺 Tissue array slides are shipped in room temperature.
  • 􀁺 If the slides are stored in 4 degree, they are good up to one year.

How processed

  • 􀁺 Tissues were initially fixed with formalin except for some of the animal tissues.
  • 􀁺 Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
  • 􀁺 Cleared by xylene, three changes for 1 hour each.
  • 􀁺 Infiltrated with 60°C paraffin, three changes for 1 hour each
  • 􀁺 Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)

Before use

  • 􀁺 Dry slides for 1 hour in a oven at 60 degree.
  • 􀁺 Dewax slides in xylene for 4 minutes x 5 times
  • 􀁺 Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
  • 􀁺 Immerse slides in tap water for 5 minutes

Slide orientation

  • 􀁺 In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.

Shaded area
1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60